605
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Anti-Inflammatory Metabolite Production in the Gut from the Consumption of Probiotic Yogurt Containing Bifidobacterium animalis subsp. lactis LKM512

&
Pages 1287-1292 | Received 06 Sep 2005, Accepted 20 Feb 2006, Published online: 22 May 2014

  • 1) Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E., and Salminen, S., Probiotics in the management of atopic eczema. Clin. Exp. Allergy, 30, 1604–1610 (2000).
  • 2) Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet, 357, 1076–1079 (2001).
  • 3) Shimada, T., Cheng, L., Enomoto, T., Yang, X., Miyoshi, A., and Shirakawa, T., Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. J. Investig. Allergol. Clin. Immunol., 14, 187–192 (2004).
  • 4) Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., and Paerregaard, A., Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol., 111, 389–395 (2003).
  • 5) Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., De Simone, C., and Sartor, R. B., VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol., 100, 1539–1546 (2005).
  • 6) Fedorak, R. N., and Madsen, K. L., Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis., 10, 286–299 (2004).
  • 7) Hessle, C., Andersson, B., and Wold, A. E., Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun., 68, 3581–3586 (2000).
  • 8) Karlsson, H., Larsson, P., Wold, A. E., and Rudin, A., Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendric cells. Infect. Immun., 72, 2671–2678 (2004).
  • 9) Kimoto, H., Mizumachi, K., Okamoto, T., and Kurisaki, J., New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol. Immunol., 48, 75–82 (2004).
  • 10) Moore, W., and Holdman, L., Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl. Microbiol., 27, 961–979 (1974).
  • 11) Finegold, S. M., Sutter, V. L., and Mathisen, G. E., Normal indigenous flora. In “Human Intestinal Microflora in Health and Disease,” ed. Hentges, D. J., Academic Press, New York, pp. 3–31 (1983).
  • 12) Matsumoto, M., and Benno, Y., Anti-inflammatory and antimutagenic activity of polyamines produced by Bifidobacterium lactis LKM512. Curr. Top. Neutraceutical Res., 2, 219–226 (2004).
  • 13) Matsumoto, M., Ohishi, H., and Benno, Y., H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int. J. Food Microbiol., 93, 109–113 (2004).
  • 14) Matsumoto, M., Tani, H., Ono, H., Ohishi, H., and Benno, Y., Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr. Microbiol., 44, 212–215 (2002).
  • 15) Matsumoto, M., Tadenuma, T., Nakamura, K., Kume, H., Imai, T., Kihara, R., Watanabe, M., and Benno, Y., Effect of Bifidobacterium lactis LKM 512 yoghurt on fecal microflora in middle to old aged persons. Microbial Ecol. Health Dis., 12, 77–80 (2000).
  • 16) Matsumoto, M., Imai, T., Hironaka, T., Kume, H., Watanabe, M., and Benno, Y., Effect of yoghurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. J. Intest. Microbiol. (in Japanese with English summary), 14, 97–102 (2001).
  • 17) Matsumoto, M., Ohishi, H., and Benno, Y., Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol. Med. Microbiol., 31, 181–186 (2001).
  • 18) Matsumoto, M., and Benno, Y., Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat. Res. Fund. Mol. Mechan. Mutagenesis, 568, 147–153 (2004).
  • 19) Dobryszycka, W., Haptoglobin: retrospectives and perspectives. In “Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications,” eds. Mackiewicz, A., Kushner, I., and Baumann, H., CRC Press, Boca Raton, pp. 185–206 (1993).
  • 20) Liu, W., Marsh, T. L., Cheng, H., and Forney, L., Characterization of microbial diversity by determining terminal restriction fragment length polymorphism of genes encoding 16S rRNA. Appl. Environ. Microbiol., 63, 4516–4522 (1997).
  • 21) Sakamoto, M., Hayashi, H., and Benno, Y., Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities. Microbiol. Immunol., 47, 133–142 (2003).
  • 22) Hayashi, H., Sakamoto, M., Kitahara, M., and Benno, Y., Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol. Immunol., 47, 557–570 (2003).
  • 23) Pena, J. A., and Versalovic, J., Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell. Microbiol., 5, 277–285 (2003).
  • 24) Pegg, A. E., and McCann, P. P., Polyamine metabolism and function. Am. J. Physiol., 243, C212–C221 (1982).
  • 25) Medina, M. A., Urdiales, J. L., Rodriguez-Caso, C., Ramirez, J., and Sanchez-Jimenez, F., Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications. Crit. Rev. Biochem. Mol. Biol., 38, 23–59 (2003).
  • 26) Dufour, C., Dandrifosse, G., Forget, P., Vermesse, F., Romain, N., and Lepoint, A., Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology, 95, 112–116 (1988).
  • 27) Wang, J.-Y., McCormack, S., Viar, M.-J., and Johnson, L., Stimulation of proximal small intestinal mucosal growth by luminal polyamines. Am. J. Physiol., 261, G504–G511 (1991).
  • 28) Buts, J.-P., de Ketser, N., Kolanowski, J., Spkal, E., and van Hoof, F., Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig. Dis. Sci., 38, 1091–1098 (1993).
  • 29) Capano, G., Bloch, K. J., Schiffrin, E. J., Dascoli, J. A., Israel, E. J., and Harmatz, P. R., Influence of the polyamine, spermidine, on intestinal maturation and dietary antigen uptake in the neonatal rat. J. Pediatr. Gastroenterol. Nutr., 19, 34–42 (1994).
  • 30) Deloyer, P., Peulen, O., and Dandrifosse, G., Dietary polyamines and non-neoplastic growth and disease. Eur. J. Gastroenterol. Hepatol., 13, 1027–1032 (2001).
  • 31) Bardocz, S., Grant, G., Brown, D. S., and Pusztai, A., Putrescine as source of instant energy in the small intestine of the rat. Gut, 42, 24–28 (1998).
  • 32) Milovic, V., Polyamines in the gut lumen: bioavailability and biodistribution. Eur. J. Gastroenterol. Hepatol., 13, 1021–1025 (2001).
  • 33) Uda, K., Tsujikawa, T., Fujiyama, Y., and Bamba, T., Rapid absorption of luminal polyamines in a rat small intestine ex vivo model. J. Gastroenterol. Hepatol., 18, 554–559 (2003).
  • 34) Szabo, C., Southan, G. J., Wood, E., Thiemermann, C., and Vane, J. R., Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor. Br. J. Pharmacol., 112, 355–356 (1994).
  • 35) Zhang, M., Caragine, T., Wang, H., Cohen, P. S., Botchkina, G., Soda, K., Bianchi, M., Ulrich, P., Cerami, A., Sherry, B., and Tracey, K., Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J. Exp. Med., 185, 1759–1768 (1997).
  • 36) Zhang, M., Borovikova, L. V., Wang, H., Metz, C., and Tracey, K. J., Spermine inhibition of monocyte activation and inflammation. Mol. Med., 5, 595–605 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.